Mealey's (March 4, 2020, 12:16 PM EST) -- NEW YORK — Bristol-Myers Squibb Co. (BMS) on Feb. 24 said that in January, it reached an agreement-in-principle to resolve a federal court whistleblower lawsuit that it inaccurately reported its average manufacturer drug prices to the U.S. Centers for Medicare and Medicaid Services....